Brain Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Cancer, including details on symptoms, benign and malignant tumors, gliomas, treatment.

Volume 7 (2010), Issue 4 (April)

1. Intraoperative magnetic resonance imaging in the surgical treatment of cerebral metastases.
   J Surg Oncol, 101(5): 436-41. [Abstract] [Full-text]
2. The nuclear receptor tailless induces long-term neural stem cell expansion and brain tumor initiation.
   Genes Dev, 24(7): 683-95. [Abstract] [Full-text]
3. Pretreatment tumoural perfusion correlates with an imaging-based response to dexamethasone in patients with glioblastoma multiforme.
   J Neurol Neurosurg Psychiatry, 81(4): 446-8. [Abstract] [Full-text]
4. FoxM1B regulates NEDD4-1 expression, leading to cellular transformation and full malignant phenotype in immortalized human astrocytes.
   Cancer Res, 70(7): 2951-61. [Abstract] [Full-text]
5. CpG island hypermethylation in human astrocytomas.
   Cancer Res, 70(7): 2718-27. [Abstract] [Full-text]
6. Heterozygosity status of 1p and 19q and its correlation with p53 protein expression and EGFR amplification in patients with astrocytic tumors: novel series from India.
   Cancer Genet Cytogenet, 198(2): 126-34. [Abstract] [Full-text]
7. Alpha-actinin 1 and alpha-actinin 4: contrasting roles in the survival, motility, and RhoA signaling of astrocytoma cells.
   Exp Cell Res, 316(7): 1137-47. [Abstract] [Full-text]
8. Molecular interaction and functional regulation of ClC-3 by Ca2+/calmodulin-dependent protein kinase II (CaMKII) in human malignant glioma.
   J Biol Chem, 285(15): 11188-96. [Abstract] [Full-text]
9. Isolation of cancer stem-like cells from a side population of a human glioblastoma cell line, SK-MG-1.
   Cancer Lett, 291(2): 150-7. [Abstract] [Full-text]
10. Single-stage bilateral choroid plexectomy for choroid plexus papilloma in a patient presenting with high cerebrospinal fluid output.
    J Neurosurg Pediatr, 5(4): 342-5. [Abstract] [Full-text]
11. Tumor vessel biology in pediatric intracranial ependymoma.
    J Neurosurg Pediatr, 5(4): 335-41. [Abstract] [Full-text]
12. Postoperative cerebellar mutism syndrome following treatment of medulloblastoma: neuroradiographic features and origin.
    J Neurosurg Pediatr, 5(4): 329-34. [Abstract] [Full-text]
13. Maximizing the extent of tumor resection during transsphenoidal surgery for pituitary macroadenomas: can endoscopy replace intraoperative magnetic resonance imaging?
    J Neurosurg, 112(4): 736-43. [Abstract] [Full-text]
14. Immunotherapy can reject intracranial tumor cells without damaging the brain despite sharing the target antigen.
    J Immunol, 184(8): 4269-75. [Abstract] [Full-text]
15. Gonadotropin-positive pituitary tumors accompanied by ovarian tumors in aging female ERbeta-/- mice.
    Proc Natl Acad Sci U S A, 107(14): 6453-8. [Abstract] [Full-text]
16. Glycitein inhibits glioma cell invasion through down-regulation of MMP-3 and MMP-9 gene expression.
    Chem Biol Interact, 185(1): 18-24. [Abstract] [Full-text]
17. Prognostic factors in prolactin pituitary tumors: clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up.
    J Clin Endocrinol Metab, 95(4): 1708-16. [Abstract] [Full-text]
18. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.
    J Clin Oncol, 28(11): 1963-72. [Abstract] [Full-text]
19. Determinants of survival in patients with brain metastases from cutaneous melanoma.
    Br J Cancer, 102(8): 1213-8. [Abstract] [Full-text]
20. A hierarchy of self-renewing tumor-initiating cell types in glioblastoma.
    Cancer Cell, 17(4): 362-75. [Abstract] [Full-text]
21. Arsenic trioxide-mediated Notch pathway inhibition depletes the cancer stem-like cell population in gliomas.
    Cancer Lett, 292(1): 64-72. [Abstract] [Full-text]
22. Tissue plasminogen activator and urokinase plasminogen activator in human epileptogenic pathologies.
    Neuroscience, 167(3): 929-45. [Abstract] [Full-text]
23. Epigenomic analysis of Alu repeats in human ependymomas.
    Proc Natl Acad Sci U S A, 107(15): 6952-7. [Abstract] [Full-text]
24. Mig-6 controls EGFR trafficking and suppresses gliomagenesis.
    Proc Natl Acad Sci U S A, 107(15): 6912-7. [Abstract] [Full-text]
25. Radiotherapy for brain metastases from renal cell cancer: should whole-brain radiotherapy be added to stereotactic radiosurgery?: analysis of 88 patients.
    Strahlenther Onkol, 186(4): 210-7. [Abstract] [Full-text]
26. Commentary on Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial (Lancet Oncol. 2009;10:459-466).
    Cancer, 116(8): 1844-6. [Abstract] [Full-text]
27. The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects.
    Cancer Res, 70(8): 3299-308. [Abstract] [Full-text]
28. Pharmacologic inhibition of cyclin-dependent kinases 4 and 6 arrests the growth of glioblastoma multiforme intracranial xenografts.
    Cancer Res, 70(8): 3228-38. [Abstract] [Full-text]
29. Phase I/II trial of hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme.
    Int J Radiat Oncol Biol Phys, 77(1): 98-105. [Abstract] [Full-text]
30. Incidence, risks, and sequelae of posterior fossa syndrome in pediatric medulloblastoma.
    Int J Radiat Oncol Biol Phys, 77(1): 106-12. [Abstract] [Full-text]
31. A phase I dose-escalation study (ISIDE-BT-1) of accelerated IMRT with temozolomide in patients with glioblastoma.
    Int J Radiat Oncol Biol Phys, 77(1): 92-7. [Abstract] [Full-text]
32. Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma.
    Int J Radiat Oncol Biol Phys, 77(1): 113-8. [Abstract] [Full-text]
33. Nomogram to predict subsequent brain metastasis in patients with metastatic breast cancer.
    J Clin Oncol, 28(12): 2032-7. [Abstract] [Full-text]
34. Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study.
    J Clin Oncol, 28(12): 2051-7. [Abstract] [Full-text]
35. TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors.
    J Clin Oncol, 28(12): 1995-2001. [Abstract] [Full-text]
36. Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases.
    Hum Pathol, 41(5): 653-62. [Abstract] [Full-text]
37. Translational research in brain metastasis is identifying molecular pathways that may lead to the development of new therapeutic strategies.
    Eur J Cancer, 46(7): 1204-10. [Abstract] [Full-text]
38. Detection of cell-free RNA in children with neuroblastoma and comparison with that of whole blood cell RNA.
    Pediatr Blood Cancer, 54(7): 897-903. [Abstract] [Full-text]
39. Clinicopathologic study of glioblastoma in children with neurofibromatosis type 1.
    Pediatr Blood Cancer, 54(7): 890-6. [Abstract] [Full-text]
40. Suberoylanilide hydroxamic acid limits migration and invasion of glioma cells in two and three dimensional culture.
    Cancer Lett, 292(2): 215-27. [Abstract] [Full-text]
41. The role of surgery in clinical management of patients with metastatic papillary renal cell carcinoma.
    J Cancer Res Clin Oncol, 136(6): 905-10. [Abstract] [Full-text]
42. Peptide-based interference of the transmembrane domain of neuropilin-1 inhibits glioma growth in vivo.
    Oncogene, 29(16): 2381-92. [Abstract] [Full-text]
43. Brain MRI with single-dose (0.1 mmol/kg) Gadobutrol at 1.5 T and 3 T: comparison with 0.15 mmol/kg Gadoterate meglumine.
    AJR Am J Roentgenol, 194(5): 1337-42. [Abstract] [Full-text]
44. Imaging of metastatic CNS neuroblastoma.
    AJR Am J Roentgenol, 194(5): 1223-9. [Abstract] [Full-text]
45. Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma.
    Nat Rev Cancer, 10(5): 319-31. [Abstract] [Full-text]
46. Glioblastoma: a method for predicting response to antiangiogenic chemotherapy by using MR perfusion imaging--pilot study.
    Radiology, 255(2): 622-8. [Abstract] [Full-text]
47. Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment.
    Radiology, 255(2): 415-25. [Abstract] [Full-text]
48. Glutathione S-transferase polymorphisms are associated with survival in anaplastic glioma patients.
    Cancer, 116(9): 2242-9. [Abstract] [Full-text]
49. Pituitary apoplexy after cardiac surgery.
    Ann Thorac Surg, 89(5): 1635-7. [Abstract] [Full-text]
50. The use of submicron/nanoscale PLGA implants to deliver paclitaxel with enhanced pharmacokinetics and therapeutic efficacy in intracranial glioblastoma in mice.
    Biomaterials, 31(19): 5199-207. [Abstract] [Full-text]
51. Complete disappearance of a GH-secreting pituitary macroadenoma in a patient with acromegaly: effect of treatment with lanreotide Autogel and consequence of treatment withdrawal.
    Eur J Endocrinol, 162(5): 993-9. [Abstract] [Full-text]
52. CD40 is a regulator for vascular endothelial growth factor in the tumor microenvironment of glioma.
    J Neuroimmunol, 222(1): 62-9. [Abstract] [Full-text]
53. Low-dose ethanol suppresses 17beta-estradiol activity in GH4C1 pituitary tumor cells.
    Cell Biol Toxicol, 26(3): 265-77. [Abstract] [Full-text]
54. Expression of hydroxyindole-O-methyltransferase enzyme in the human central nervous system and in pineal parenchymal cell tumors.
    J Neuropathol Exp Neurol, 69(5): 498-510. [Abstract] [Full-text]
55. Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma.
    J Clin Oncol, 28(13): 2293-9. [Abstract] [Full-text]
56. Anti-vascular endothelial growth factor therapies as a novel therapeutic approach to treating neurofibromatosis-related tumors.
    Cancer Res, 70(9): 3483-93. [Abstract] [Full-text]
57. Astrocyte elevated gene-1 upregulates matrix metalloproteinase-9 and induces human glioma invasion.
    Cancer Res, 70(9): 3750-9. [Abstract] [Full-text]
58. Sleeping beauty-mediated somatic mutagenesis implicates CSF1 in the formation of high-grade astrocytomas.
    Cancer Res, 70(9): 3557-65. [Abstract] [Full-text]

© 2004-2012 Brain Cancer Research Today. All Rights Reserved.